Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 16 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Roche Holding AG, Sanofi, Roche Holding AG, Viatris Inc., Astrazeneca PLC, Glaxosmithkline PLC, Bristol-Myers Squibb Co, Merck & Co Inc, Novartis AG, Organon & Co, Zoetis Inc, Johnson & Johnson, Pfizer Inc, Catalent Inc, Eli Lilly and Co and Novo Nordisk A/S.
1/14/2022 Health Care Sector Pharmaceuticals Industry
$16,871
Change: -0.50%
Open: $16,908
High: $17,012
Low: $16,742
| Roche Holding AG (RHHBF) |
+3.51%
|
| Sanofi (SNY) |
+2.37%
|
| Roche Holding AG (RHHBY) |
+1.66%
|
| Viatris Inc. (VTRS) |
+1.33%
|
| Astrazeneca PLC (AZN) |
+1.29%
|
| Glaxosmithkline PLC (GSK) |
+0.91%
|
| Bristol-Myers Squibb Co (BMY) |
+0.51%
|
| Merck & Co Inc (MRK) |
+0.07%
|
| Novartis AG (NVS) |
-0.08%
|
| Organon & Co (OGN) |
-0.12%
|
| Zoetis Inc (ZTS) |
-0.40%
|
| Pharmaceuticals Industry |
-0.50%
|
| Johnson & Johnson (JNJ) |
-0.55%
|
| Pfizer Inc (PFE) |
-1.06%
|
| Catalent Inc (CTLT) |
-1.58%
|
| Eli Lilly and Co (LLY) |
-2.22%
|
| Novo Nordisk A/S (NVO) |
-3.25%
|
Index Value: $16,871 -0.50%
Volume: 1.87B Average Volume (3 month): 2.73B
Market Capitalization: $49.50T
EBITDA: $4.41T
EPS Basic: $192.97 Diluted: $99.20 Actual: $239.26
EPS Estimation: High $235.43 Medium: $218.77 Low: $205.90
EPS TTM: $423.37
P/E: 39.97
PEG Ratio (5 year Expected): 9.71
Dividend Yield: 5.16%
Dividend Rate: $869.13
Dividend Yield (Forward): 2.60%
Dividend Rate (Forward): $440.20
Shares Outstanding: 739.73B
Book Value: $3,198
Short Ratio: 1.40
Price Target (1 year): $13,606
Volume: 1.87B Average Volume (3 month): 2.73B
Market Capitalization: $49.50T
EBITDA: $4.41T
EPS Basic: $192.97 Diluted: $99.20 Actual: $239.26
EPS Estimation: High $235.43 Medium: $218.77 Low: $205.90
EPS TTM: $423.37
P/E: 39.97
PEG Ratio (5 year Expected): 9.71
Dividend Yield: 5.16%
Dividend Rate: $869.13
Dividend Yield (Forward): 2.60%
Dividend Rate (Forward): $440.20
Shares Outstanding: 739.73B
Book Value: $3,198
Short Ratio: 1.40
Price Target (1 year): $13,606
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| RHHBF | Roche Holding AG | 434.76 | +3.51% | 7 | 0.04 | 0.00% |
| SNY | Sanofi | 51.93 | +2.37% | 1.98M | 1.27 | 5.62% |
| RHHBY | Roche Holding AG | 50.30 | +1.66% | 2.23M | 2.20 | 0.01% |
| VTRS | Viatris Inc. | 15.22 | +1.33% | 5.59M | 0.55 | 0.79% |
| AZN | Astrazeneca PLC | 58.85 | +1.29% | 5.00M | 1.11 | 7.84% |
| GSK | Glaxosmithkline PLC | 45.47 | +0.91% | 3.33M | 0.83 | 4.92% |
| BMY | Bristol-Myers Squibb Co | 64.93 | +0.51% | 9.07M | 0.69 | 6.19% |
| MRK | Merck & Co Inc | 81.38 | +0.07% | 9.48M | 0.68 | 8.83% |
| NVS | Novartis AG | 90.55 | -0.08% | 1.57M | 0.64 | 8.70% |
| OGN | Organon & Co | 32.86 | -0.12% | 1.76M | 0.86 | 0.36% |
| ZTS | Zoetis Inc | 206.18 | -0.40% | 2.09M | 1.27 | 4.19% |
| Pharmaceuticals Industry | 16,870.56 | -0.50% | 1.87B | 0.68 | 37.90% | |
| JNJ | Johnson & Johnson | 167.84 | -0.55% | 5.59M | 0.75 | 18.99% |
| PFE | Pfizer Inc | 54.95 | -1.06% | 26.64M | 0.62 | 13.25% |
| CTLT | Catalent Inc | 108.24 | -1.58% | 1.27M | 1.22 | 0.80% |
| LLY | Eli Lilly and Co | 244.12 | -2.22% | 2.86M | 0.93 | 10.03% |
| NVO | Novo Nordisk A/S | 96.32 | -3.25% | 2.44M | 2.06 | 9.47% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| RHHBF | Roche Holding AG | 344.078B | N/A | N/A | 2.17% | |
| SNY | Sanofi | 130.374B | $5.26 | 9.87 | 6.31% | 1.32 |
| RHHBY | Roche Holding AG | 348.39B | N/A | N/A | 18.39% | |
| VTRS | Viatris Inc. | 18.407B | -$1.80 | N/A | 2.20% | -11.17 |
| AZN | Astrazeneca PLC | 182.364B | $0.96 | 61.30 | 6.37% | 0.88 |
| GSK | Glaxosmithkline PLC | 114.398B | $2.87 | 15.84 | 1.78% | 3.63 |
| BMY | Bristol-Myers Squibb Co | 144.132B | -$2.40 | N/A | 3.03% | 1.40 |
| MRK | Merck & Co Inc | 205.536B | $2.06 | 39.50 | 3.15% | 0.92 |
| NVS | Novartis AG | 202.591B | $3.95 | 22.92 | 3.75% | 2.07 |
| OGN | Organon & Co | 8.332B | N/A | N/A | 0.85% | -0.93 |
| ZTS | Zoetis Inc | 97.525B | $3.99 | 51.67 | 0.46% | 3.37 |
| Pharmaceuticals Industry | $49.50T | $423.37 | 39.97 | 5.16% | 9.71 | |
| JNJ | Johnson & Johnson | 441.75B | $6.69 | 25.09 | 2.45% | 2.12 |
| PFE | Pfizer Inc | 308.427B | $2.18 | 25.21 | 2.79% | 0.01 |
| CTLT | Catalent Inc | 18.54B | $3.09 | 35.03 | 1.95 | |
| LLY | Eli Lilly and Co | 233.552B | $6.67 | 36.60 | 1.32% | 5.06 |
| NVO | Novo Nordisk A/S | 219.496B | $3.17 | 30.38 | 9.39% | 116.24 |
Back to Market Summary